Biospeedia
Founded 2011 · 2 employees on LinkedIn · 1 known investors
Find your way into Biospeedia
13 people in our graph share verified history with the Biospeedia team — schools, employers, funds. One of them is your warm intro.
Pascal Cagniunlockedknows Yves Germani · together at Business France (Export) (overlapped)
×10knows the team · via Business France (Export)
knows the team · via Biospeedia
BioSpeedia is a biotechnology company that develops and produces rapid lateral-flow diagnostic tests for infectious diseases, including tests for bacterial meningitis and SARS-CoV-2. A spin-off from the Institut Pasteur, it distributes its diagnostic products worldwide through affiliated entities.
Founders & leadership
Biospeedia was founded in 2011 by Evelyne Begaud and Yves Germani.
EB
Evelyne BegaudCo-founder & President
YG
Yves GermaniinCo-founder & Chief Scientific OfficerYves Germani holds PhDs in Pharmaceutical Sciences and Natural Sciences, and spent over 16 years as a research director at Institut Pasteur leading infectious disease programs across Africa and Asia. He previously served as head of the health department at UBIFRANCE in New York and now works as Chief Scientific Officer of BioSpeedia and president of XPERTS-AND-BEYOND, a biotechnology consulting firm.
Investors · 1
Frequently asked questions
- What does Biospeedia do?
- BioSpeedia is a biotechnology company that develops and produces rapid lateral-flow diagnostic tests for infectious diseases, including tests for bacterial meningitis and SARS-CoV-2. A spin-off from the Institut Pasteur, it distributes its diagnostic products worldwide through affiliated entities.
- Who founded Biospeedia?
- Biospeedia was founded by Evelyne Begaud, Yves Germani in 2011.
- Who are Biospeedia's investors?
- Biospeedia's investors include Forepont Capital Partners.